International Journal of Gynecological Cancer

Clinical applications of immunohistochemistry in gynecological malignancies
pp. 311-315(5)
Authors: SHUTTER,; ATKINS,; GHARTEY,; HERZOG,

Current management of ovarian carcinosarcoma
pp. 316-324(9)
Authors: MANO,; ROSA,; AZAMBUJA,; ISMAEL,; BRAGA,; D'HONDT,; PICCART,; AWADA,

Hormonal therapy in ovarian cancer
pp. 325-338(14)
Authors: ZHENG,; KAVANAGH,; HU,; LIAO,; FU,

Treatment of incidental adnexal masses at cesarean section: a retrospective study
pp. 339-341(3)
Authors: DEDE,; YENEN,; YILMAZ,; GOKTOLGA,; BASER,

Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004
pp. 342-349(8)
Authors: WONG,; LOW,; CHUA,; BUSMANIS,; TAY,; HO,

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer
pp. 350-358(9)
Authors: FRIEDLANDER,; BUCK,; WYLD,; FINDLAY,; FITZHARRIS,; DE SOUZA,; DAVIES,; KALIMI,; ALLAN,; PEREZ,; HARNETT,

Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study
pp. 359-366(8)
Authors: HARNETT,; BUCK,; BEALE,; GOLDRICK,; ALLAN,; FITZHARRIS,; deSOUZA,; LINKS,; KALIMI,; DAVIES,; STUART-HARRIS,

A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer
pp. 367-372(6)
Authors: VECCHIONE,; FRUSCIO,; DELL'ANNA,; GARBI,; GARCIA PARRA,; CORSO,; LISSONI,

Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial
pp. 373-378(6)
Authors: MORGAN,; SYNOLD,; GANDARA,; MUGGIA,; SCUDDER,; REED,; MARGOLIN,; RASCHKO,; LEONG,; SHIBATA,; TETEF,; VASILEV,; McGONIGLE,; LONGMATE,; YEN,; CHOW,; SOMLO,; CARROLL,; DOROSHOW,

A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer
pp. 379-386(8)
Authors: LEISER,; MALUF,; CHI,; SABBATINI,; HENSLEY,; SCHWARTZ,; VENKATRAMAN,; SPRIGGS,; AGHAJANIAN,

Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study
pp. 387-393(7)
Authors: HUANG,; BRADY,; CELLA,; FLEMING,

Discordance of clinical symptoms and electrophysiologic findings in taxane plus platinum-induced neuropathy
pp. 394-397(4)
Authors: PAN,; KAO,

Molecular characterization of sarcomatous change in a granulosa cell tumor
pp. 398-406(9)
Authors: McNEILAGE,; ALEXIADIS,; SUSIL,; MAMERS,; JOBLING,; LASLETT,; TRAJSTMAN,; FULLER,

Characterization of an intraperitoneal ovarian cancer xenograft model in nude rats using noninvasive microPET imaging
pp. 407-417(11)
Authors: ZAVALETA,; PHILLIPS,; BRADLEY,; McMANUS,; JERABEK,; GOINS,

Peroxisome proliferator-activated receptor-γ agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines
pp. 418-425(8)
Authors: YANG,; TSAO,; HO,; CHOUNG,

Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer
pp. 426-432(7)
Authors: NAKAZATO,; KANUMA,; TAMURA,; FARIED,; AOKI,; MINEGISHI,

Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study
pp. 433-440(8)
Authors: KWON,; CAREY,; COOK,; QIU,; PASZAT,

Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis
pp. 441-446(6)
Authors: CHIA,; NEWCOMB,; TRENTHAM-DIETZ,; HAMPTON,

Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression
pp. 447-454(8)
Authors: WOOD,; QUINTON,; BURDALL,; SHERIDAN,; DUFFY,

Clinical efficacy of conservative laser therapy for early-stage cervical cancer
pp. 455-459(5)
Authors: YAMAGUCHI,; UEDA,; KANEMURA,; IZUMA,; NISHIYAMA,; TANAKA,; NODA,

Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey
pp. 460-464(5)
Authors: TANAKA,; OHKI,; KOJIMA,; MAENO,; MIYAHARA,; SUDO,; TAKEKIDA,; YAMAGUCHI,; SASAKI,; NISHIMURA,

The prognostic significance of leukocytosis in cervical cancer
pp. 465-470(6)
Authors: GARCIA-ARIAS,; CETINA,; CANDELARIA,; ROBLES,; DUEÑAS-GONZÁLEZ,

Sentinel lymph node identification in a primary ductal carcinoma arising in the vulva
pp. 471-477(7)
Authors: MARTINEZ-PALONES,; PEREZ-BENAVENTE,; DIAZ-FEIJOO,; GIL-MORENO,; ROCA,; GARCÍA-JIMENEZ,; AGUILAR-MARTINEZ,; XERCAVINS,

Study on CXCR4/SDF-1α axis in lymph node metastasis of cervical squamous cell carcinoma
pp. 478-483(6)
Authors: ZHANG,; LU,; YE,; CHEN,; ZHOU,; XIE,

Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells
pp. 484-491(8)
Authors: VAZQUEZ-ORTIZ,; GARCÍA,; CIUDAD,; NOÉ,; PEÑUELAS,; LÓPEZ-ROMERO,; MENDOZA-LORENZO,; PIÑA-SÁNCHEZ,; SALCEDO,

Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer
pp. 492-496(5)
Authors: KANG,; KIM,; PARK,; SONG,; LEE,

Human papillomavirus genotyping using HPV DNA chip analysis in Korean women
pp. 497-501(5)
Authors: LEE,; KIM,; CHOI,; NAM,; PARK,

Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition
pp. 502-510(9)
Authors: YAO,; DUAN,; FAN,; YUAN,; WU,

Blocking Notch1 signaling by RNA interference can induce growth inhibition in HeLa cells
pp. 511-516(6)
Authors: YU,; ZHAO,; HUANG,; JIAN,; QIAN,; GE,

Lymph node recurrence following stage IA vulvar carcinoma: two cases and a short overview of literature
pp. 517-520(4)
Authors: VERNOOIJ,; SIE-GO,; HEINTZ,

Langerhans cell histiocytosis of vulva in adolescent
pp. 520-524(5)
Authors: MOTTL,; ROB,; STARY,; KODET,; DRAHOKOUPILOVA,

Primitive neuroectodermal tumor of the uterus: a case report
pp. 524-527(4)
Authors: MITTAL,; SUMANA,; GUPTA,

Primary retroperitoneal lymphangioleiomyomatosis in a postmenopausal woman: a case report and review of the literature
pp. 528-532(5)
Authors: KEBRIA,; BLACK,; BORELLI,; MODICA,; HENSLEY,; CHI,

Endometrial lymphoepitheliomalike carcinoma: absence of Epstein-Barr virus genomes
pp. 532-535(4)
Authors: RAHIMI,; LENA,; VITTORI,

Vaginal reconstruction with a greater omentum-pedicled graft combined with a vicryl mesh after anterior pelvic exenteration. Surgical approach with long-term follow-up
pp. 536-542(7)
Authors: ELAFFANDI,; KHALIL,; ABOUL KASSEM,; EL SHERBINY,; EL GEMEIE,

To the Editor
pp. 543-543(1)

Letter
pp. 544-544(1)

Response to the letter of Dr Thomas
pp. 545-545(1)